Internal Medicine, Hematology & Oncology · Little Rock, AR
NPI
1891834016
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
8901 Carti Way
Little Rock, AR, 72205
Phone (501) 906-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.6M
83,446 services
Medicare patients, 2024
906
Average age 74
Drug cost, 2024
$4.9M
3,606 prescriptions
Company payments, 2025
$20.44
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rhonda Gentry was code J9299 (injection, nivolumab, 1 mg), 8,940 times for 11 patients. In total Rhonda Gentry billed 83,446 services in 169 codes, and Medicare paid $1.6M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-03-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9299 Injection, nivolumab, 1 mg | Office | 8,940 | 11 | $24.65 | $220K |
| J0897 Injection, denosumab, 1 mg | Office | 3,660 | 17 | $20.64 | $76K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 3,600 | 13 | $44.86 | $162K |
| 85025 Blood Count | Office | 2,701 | 666 | $7.57 | $20K |
| 80053 Clinical Chemistry | Office | 2,494 | 643 | $10.31 | $26K |
| 36415 Venipuncture Blood Collection | Office | 2,324 | 630 | $8.64 | $20K |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2,020 | 26 | $6.38 | $13K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 1,900 | 18 | $15.66 | $30K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,248 | 38 | $0.09 | $113 |
| 82378 Clinical Chemistry | Office | 1,032 | 379 | $18.47 | $19K |
| 99214 Office E&M - Established | Office | 943 | 451 | $86.58 | $82K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 700 | 19 | $0.73 | $513 |
| 99215 Office E&M - Established | Office | 697 | 183 | $126.09 | $88K |
| 86300 Immunoassay | Office | 597 | 253 | $20.30 | $12K |
| 84439 Clinical Chemistry | Office | 525 | 184 | $8.84 | $4,641 |
By year: 2022 $2.0M for 130,709 services; 2023 $1.8M for 107,701 services; 2024 $1.6M for 83,446 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 2,701 | 666 | $7.57 | $20K |
| 80053 Clinical Chemistry | 2,494 | 643 | $10.31 | $26K |
| 36415 Venipuncture Blood Collection | 2,324 | 630 | $8.64 | $20K |
| 82378 Clinical Chemistry | 1,032 | 379 | $18.47 | $19K |
| 86300 Immunoassay | 597 | 253 | $20.30 | $12K |
| 84439 Clinical Chemistry | 525 | 184 | $8.84 | $4,641 |
| 84443 Clinical Chemistry | 515 | 183 | $16.46 | $8,477 |
| 82533 Clinical Chemistry | 432 | 48 | $15.97 | $6,899 |
| 82728 Clinical Chemistry | 430 | 247 | $13.32 | $5,727 |
| 82784 Immunoassay | 405 | 75 | $9.02 | $3,654 |
Medicare prescription drug claims, 2024
In 2024, the drug Rhonda Gentry prescribed most often to Medicare patients was Anastrozole, with 518 prescriptions and refills. In total Rhonda Gentry wrote 3,606 Medicare prescriptions that cost $4.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 518 | 934 | 101 | $6,288 |
| Omeprazole Generic | 314 | 487 | 72 | $2,384 |
| Letrozole Generic | 165 | 302 | 31 | $2,526 |
| Gabapentin Generic | 153 | 166 | 30 | $1,502 |
| Tamoxifen Citrate Generic | 132 | 218 | 28 | $2,996 |
| Eliquis Apixaban | 131 | 142 | 24 | $82K |
| Ondansetron Odt Ondansetron | 118 | 120 | 51 | $1,449 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 111 | 170 | 19 | $1,683 |
| Promethazine Hcl Generic | 108 | 108 | 36 | $845 |
| Cyanocobalamin Injection Cyanocobalamin (Vitamin B-12) | 97 | 129 | 26 | $1,535 |
| Ibrance Palbociclib | 63 | 63 | Under 11 | $969K |
| Levothyroxine Sodium Generic | 61 | 91 | 15 | $253 |
| Xarelto Rivaroxaban | 60 | 66 | Under 11 | $36K |
| Mirtazapine Generic | 60 | 92 | 15 | $684 |
| Neulasta Onpro Pegfilgrastim | 56 | 56 | 17 | $348K |
Brand drugs: 734 claims; generic drugs: 2,853 claims; opioid claims: 104.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rhonda Gentry $20.44 ($20.44 in general payments such as food, travel and fees) from 2 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $20.44.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 1 | $20.44 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.